Natera Inc
NASDAQ:NTRA

Watchlist Manager
Natera Inc Logo
Natera Inc
NASDAQ:NTRA
Watchlist
Price: 140.65 USD -0.54% Market Closed
Market Cap: 19B USD

P/OCF
Price to OCF

137.5
Current
-14.9
Median
20
Industry
Higher than median
Higher than industry value

Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.

P/OCF
137.5
=
Market Cap
18.7B USD
/
Operating Cash Flow
135.7m USD
Market Cap P/OCF
US
Natera Inc
NASDAQ:NTRA
18.7B USD 137.5
FR
Pharnext SCA
OTC:PNEXF
6T USD -231 013.7
US
Abbvie Inc
NYSE:ABBV
364.1B USD 19.4
US
Amgen Inc
NASDAQ:AMGN
164.8B USD 14.3
US
Gilead Sciences Inc
NASDAQ:GILD
138.7B USD 12.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
124.5B USD -252.8
US
Epizyme Inc
F:EPE
94.1B EUR -487
AU
CSL Ltd
ASX:CSL
123.6B AUD 26.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
67.6B USD 15.3
US
Seagen Inc
F:SGT
39.3B EUR -78.6
NL
argenx SE
XBRU:ARGX
32.5B EUR -135.2

P/OCF Forward Multiples

Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/OCF
N/A
2-Years Forward
P/OCF
N/A
3-Years Forward
P/OCF
N/A